Back to results
US 2011/0301231 A1Published application
Lipase inhibiting composition
AssigneeHoffmann-La Roche Inc.
InventorsKarsten MAEDER, Rainer Eugen Martin, Susanne Raab, Lukas Christoph Scheibler, Thomas Schindler, Marco Shroeder
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions that contain a lipase inhibitor having a melting point ≧37° C., a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable excipients, are useful for treatment of obesity.
Claims18
A pharmaceutical composition comprising
- (i) orlistat;
- (ii) a sucrose fatty acid ester or a mixture of sucrose fatty acid esters, wherein the sucrose fatty acid ester comprises a sucrose moiety and at least one to at least four fatty acid moieties, and wherein the sucrose fatty acid ester or mixture of sucrose fatty acid esters;
- and
- (iii) one or more pharmaceutically acceptable excipients.
1 more element
Dependencies are inferred from the claim text.